Frederick Wolf, J.D., M.S. is a seasoned legal professional specializing in intellectual property and transactions, currently serving as Sr. Director of IP & Transactions at Novavax since June 2022. Previous roles include Sr. Intellectual Property Counsel at the Broad Institute of MIT and Harvard and Senior Intellectual Property Counsel at NantWorks, among others. Frederick has extensive experience in patent strategy, coordination with clinical development teams, and advising on legal matters related to a diverse range of pharmaceutical products. Education includes a Juris Doctor from American University Washington College of Law, a Master of Science in Biotechnology from The Johns Hopkins University, and a Bachelor of Science in Biology from Wittenberg University.
This person is not in any teams
This person is not in any offices